Stratos Genomics raises $4M in Series-A round

Stratos Genomics, a Seattle-based startup focusing on low-cost DNA sequencing technology, closed a $4 million Series-A financing round led by Fisk Ventures. “The Stratos Genomics technology has the potential to revolutionize personalized medicine and bring genome sequencing technology to all. If our goals are realized, Stratos Genomics will have a huge impact on life sciences,” said Stephen Rose, managing director of Fisk Ventures.

Learn more at Stratos Genomics
Stratos Genomics is a WTC client

This entry was posted in Company_and_Client_News, Funding, Life_Sciences, Stratos_Genomics. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s